» Articles » PMID: 36613636

The Effect of Valeton (Zingiberaceae) Extract on Prion Propagation in Cell-Based and Animal Models

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jan 8
PMID 36613636
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases are neurodegenerative disorders in humans and animals for which no therapies are currently available. Here, we report that Valeton (Zingiberaceae) () extract was partly effective in decreasing prion aggregation and propagation in both in vitro and in vivo models. extract inhibited self-aggregation of recombinant prion protein (PrP) in a test tube assay and decreased the accumulation of scrapie PrP (PrP) in ScN2a cells, a cultured neuroblastoma cell line with chronic prion infection, in a concentration-dependent manner. extract also modified the course of the disease in mice inoculated with mouse-adapted scrapie prions, completely preventing the onset of prion disease in three of eight mice. Biochemical and neuropathological analyses revealed a statistically significant reduction in PrP accumulation, spongiosis, astrogliosis, and microglia activation in the brains of mice that avoided disease onset. Furthermore, PrP accumulation in the spleen of mice was also reduced. extract precluded prion infection in cultured cells as demonstrated by the modified standard scrapie cell assay. This study suggests that extract could contribute to investigating the modulation of prion propagation.

Citing Articles

The Benzoxazole Heterocycle: A Comprehensive Review of the Most Recent Medicinal Chemistry Developments of Antiproliferative, Brain-Penetrant, and Anti-inflammatory Agents.

Di Martino S, De Rosa M Top Curr Chem (Cham). 2024; 382(4):33.

PMID: 39432195 DOI: 10.1007/s41061-024-00477-6.


Isolation of Anti-Prion Compounds from Valeton Extract.

Kim J, Lee H, Kim H, Kim J, Byun S, Lee S Molecules. 2024; 29(17).

PMID: 39274884 PMC: 11397528. DOI: 10.3390/molecules29174034.


The mechanism of INO80D involved in chromatin remodeling regulating spermatogenesis in Chinese mitten crab (Eriocheir sinensis).

Mo Y, Sun L, Li S, Luo L, Liu H, Huang S Mol Genet Genomics. 2024; 299(1):83.

PMID: 39212752 DOI: 10.1007/s00438-024-02177-8.


Synthesis and anti-prion aggregation activity of acylthiosemicarbazide analogues.

Kim D, Kim J, Lee H, Lee D, Im S, Kim Y J Enzyme Inhib Med Chem. 2023; 38(1):2191164.

PMID: 36950944 PMC: 10038035. DOI: 10.1080/14756366.2023.2191164.

References
1.
Lin C, Yu K, Jheng C, Chung R, Lee C . Curcumin reduces amyloid fibrillation of prion protein and decreases reactive oxidative stress. Pathogens. 2014; 2(3):506-19. PMC: 4235698. DOI: 10.3390/pathogens2030506. View

2.
Collinge J, Gorham M, Hudson F, Kennedy A, Keogh G, Pal S . Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol. 2009; 8(4):334-44. PMC: 2660392. DOI: 10.1016/S1474-4422(09)70049-3. View

3.
Tyring S . Sinecatechins: Effects on HPV-Induced Enzymes Involved in Inflammatory Mediator Generation. J Clin Aesthet Dermatol. 2012; 5(1):19-26. PMC: 3277090. View

4.
Li L, Zhu Y, Zhou S, An X, Zhang Y, Bai Q . Experimental and Theoretical Insights into the Inhibition Mechanism of Prion Fibrillation by Resveratrol and its Derivatives. ACS Chem Neurosci. 2017; 8(12):2698-2707. DOI: 10.1021/acschemneuro.7b00240. View

5.
Prusiner S . Prions. Proc Natl Acad Sci U S A. 1998; 95(23):13363-83. PMC: 33918. DOI: 10.1073/pnas.95.23.13363. View